Graybug Vision, Inc.
(NASDAQ : GRAY)

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.11%36.710.9%$1248.49m
JNJJohnson & Johnson -0.23%160.280.7%$1180.84m
MRKMerck & Co., Inc. 1.47%83.380.7%$793.32m
ABBVAbbVie, Inc. -1.02%110.491.9%$741.62m
LLYEli Lilly & Co. 2.20%190.791.1%$736.86m
BMYBristol-Myers Squibb Co. 0.82%66.561.0%$715.48m
AZNAstraZeneca Plc 0.10%51.341.2%$669.12m
RPRXRoyalty Pharma Plc 1.37%51.950.2%$220.52m
VTRSViatris, Inc. -1.50%17.050.0%$200.69m
ARCTArcturus Therapeutics Holdings, Inc. -4.14%59.690.0%$197.04m
NVSNovartis AG 1.07%95.630.2%$176.60m
GSKGlaxoSmithKline Plc 0.80%38.470.2%$144.27m
SNYSanofi 0.73%49.390.2%$114.02m
RGENRepligen Corp. 1.52%215.476.9%$81.99m
NVONovo Nordisk A/S 1.41%72.030.1%$74.66m

Company Profile

Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA.